New research indicates that patients who come off popular GLP-1 drugs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who stop conventional lifestyle regimens.
Research printed in a prominent health publication shows that while overweight individuals frequently drop substantial amounts of their total mass while on the medication, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals using such drugs must be aware of the risk of fast weight regain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
This pace of regain suggests a reversion to pre-treatment mass in about a year and a half.
Comparing Approaches
The research, which examined 37 of trials involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.
Scientists note that individuals who shed pounds through dieting usually have a slower weight regain—approximately 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Doctors suggest the mode of action of the injections is key to understanding the accelerated regain.
The injections mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production may cause the system to produce less of its endogenous hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making excessive eating far more likely."
A Lifelong Issue?
Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals argue that, given the high risk of relapse, the therapy might need to be ongoing.
This opinion is reinforced by pharmaceutical companies, who state that the findings "emphasize the chronic nature of obesity," comparing it to managing conditions like high blood pressure.
Patient Testimonies
Individuals who have come off the jabs explain a powerful resurgence of cravings.
"It felt as if a switch that goes on and you become extremely hungry," recalled a patient.
The struggle is compounded if patients have not developed permanent lifestyle or habit changes during therapy.
Widespread Use
Survey data indicate that a significant number of people in the UK have tried these injections in the last 12 months, with desire being substantial.
- Use is higher among females compared to males.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on ongoing behavioural management.
